Literature DB >> 29713058

Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/β-catenin signaling.

Hae-Kyung Lee1, Eun-Woo Lee2, Jinho Seo1, Manhyung Jeong1, Seon-Hyeong Lee3, Soo-Youl Kim3, Eek-Hoon Jho4, Chel Hun Choi5, Joon-Yong Chung6, Jaewhan Song7.   

Abstract

The adenomatous polyposis coli (APC) protein has a tumor-suppressor function by acting as a negative regulator of the Wnt signaling pathway. While its role as a tumor suppressor is well-defined, the post-translational modifications that regulate APC stability are not fully understood. Here we showed that MKRN1, an E3 ligase, could directly interact with and ubiquitylate APC, promoting its proteasomal degradation. In contrast, an E3 ligase-defective MKRN1 mutant was no longer capable of regulating APC, indicating that its E3 ligase activity is required for APC regulation by MKRN1. Strengthening these results, MKRN1 ablation resulted in reduced β-catenin activity and decreased expression of Wnt target genes. The ability of the Wnt-dependent pathway to induce cancer cell proliferation, migration, and invasion was impaired by MKRN1 depletion, but restored by simultaneous APC knockdown. Taken together, these results demonstrate that MKRN1 functions as a novel E3 ligase of APC that positively regulates Wnt/β-catenin-mediated biological processes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29713058     DOI: 10.1038/s41388-018-0267-3

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

Review 1.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

2.  Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.

Authors:  Jun Hyun Kim; Sun-Mi Park; Mi Ran Kang; Sue-Young Oh; Tae H Lee; Mark T Muller; In Kwon Chung
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

3.  HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction.

Authors:  Hoanh Tran; Daisy Bustos; Ronald Yeh; Bonnee Rubinfeld; Cynthia Lam; Stephanie Shriver; Inna Zilberleyb; Michelle W Lee; Lilian Phu; Anjali A Sarkar; Irene E Zohn; Ingrid E Wertz; Donald S Kirkpatrick; Paul Polakis
Journal:  J Biol Chem       Date:  2012-12-31       Impact factor: 5.157

4.  Structure of Osh3 reveals a conserved mode of phosphoinositide binding in oxysterol-binding proteins.

Authors:  Junsen Tong; Huiseon Yang; Hongyuan Yang; Soo Hyun Eom; Young Jun Im
Journal:  Structure       Date:  2013-06-20       Impact factor: 5.006

5.  Methylation profiles of hereditary and sporadic ovarian cancer.

Authors:  Guus M Bol; Karijn P M Suijkerbuijk; Joost Bart; Marc Vooijs; Elsken van der Wall; Paul J van Diest
Journal:  Histopathology       Date:  2010-08-31       Impact factor: 5.087

Review 6.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

7.  ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation.

Authors:  W Kim; S Y Kim; T Kim; M Kim; D-J Bae; H-I Choi; I-S Kim; E Jho
Journal:  Oncogene       Date:  2012-08-20       Impact factor: 9.867

8.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

9.  Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.

Authors:  Michael B Major; Nathan D Camp; Jason D Berndt; Xianhua Yi; Seth J Goldenberg; Charlotte Hubbert; Travis L Biechele; Anne-Claude Gingras; Ning Zheng; Michael J Maccoss; Stephane Angers; Randall T Moon
Journal:  Science       Date:  2007-05-18       Impact factor: 47.728

Review 10.  Skeletal metastasis: treatments, mouse models, and the Wnt signaling.

Authors:  Kenneth C Valkenburg; Matthew R Steensma; Bart O Williams; Zhendong Zhong
Journal:  Chin J Cancer       Date:  2013-01-18
View more
  8 in total

1.  Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis.

Authors:  Shijian Zhao; Yinteng Wu; Yantao Wei; Xiaoyu Xu; Jialin Zheng
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

2.  Ubiquitination of P53 by E3 ligase MKRN2 promotes melanoma cell proliferation.

Authors:  Yiling Zhang; Ningning Cui; Gang Zheng
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

3.  Makorin 1 is required for Drosophila oogenesis by regulating insulin/Tor signaling.

Authors:  Eui Beom Jeong; Seong Su Jeong; Eunjoo Cho; Eun Young Kim
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

Review 4.  MRKNs: Gene, Functions, and Role in Disease and Infection.

Authors:  Tongtong Wang; Wenqiang Liu; Changfa Wang; Xuelian Ma; Muhammad Faheem Akhtar; Yubao Li; Liangliang Li
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

Review 5.  Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers.

Authors:  Hong-Beom Park; Ju-Won Kim; Kwang-Hyun Baek
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

Review 6.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10

Review 7.  Ubiquitin Ligases Involved in the Regulation of Wnt, TGF-β, and Notch Signaling Pathways and Their Roles in Mouse Development and Homeostasis.

Authors:  Nikol Baloghova; Tomas Lidak; Lukas Cermak
Journal:  Genes (Basel)       Date:  2019-10-16       Impact factor: 4.096

8.  MKRN1 Ubiquitylates p21 to Protect against Intermittent Hypoxia-Induced Myocardial Apoptosis.

Authors:  Xue Bai; Hui Yang; Jiayuan Pu; Yan Zhao; Ying Jin; Qin Yu
Journal:  Oxid Med Cell Longev       Date:  2021-08-30       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.